NewsPeople

Breakthrough glaucoma treatment OCUSERT bags patent

Dr Bala Prabhakar, Dean Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management (SPPSPTM), along with other inventors received the patent

NMIMS Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management (SPPSPTM) has announced that a patent for OCUSERT, a novel ocular formulation for the treatment of glaucoma, has been awarded (Patent No. 416859, Application no. 201721032534) to Dr Bala Prabhakar, Dean Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management (SPPSPTM), along with other inventors.

THIS CAN BE YOUR ADVERTISEMENT

The OCUSERT formulation addresses these issues by providing sustained release of the active drug over a longer period. This development has the potential for commercial applicability and could significantly improve the treatment options available for patients with glaucoma.

Dr Ramesh Bhat, Vice Chancellor of SVKM’s NMIMS, said, “The grant of this patent is a testament to the hard work and dedication of our faculty. We are thrilled to have the opportunity to make a positive impact on the lives of patients suffering from glaucoma with OCUSERT. I am glad that research is such an integral part of the University and hope that we will continue to work towards more such path-breaking outcomes.”

“OCUSERT has the potential to revolutionize the treatment of glaucoma. The sustained release capabilities of this formulation will significantly improve patient compliance and offer a more effective treatment option for a disease that affects millions of people worldwide,” said Dr Prabhakar.

 

 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Back to top button
Close
Close